CHU de Quebec-Universite Laval
CHU de Quebec-Universite Laval
Explore linked clinical trials.54 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Not applicable | 2026-10-09 | NCT05910840 | |
| Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urinary Retention, Urination Disorders, Urogenital Diseases, urinary system disorder | Recruiting | Phase 3 | 2026-09-10 | NCT05941806 | |
| Open Lung Protective Extubation Following General Anesthesia | Lung Injury, Pulmonary Atelectasis, Thoracic Injuries, Ventilator-Induced Lung Injury, injury, lung disorder, respiratory system disorder | Recruiting | Not applicable | 2026-08-17 | NCT06296173 | |
| SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma | burn, injury | Recruiting | Phase 1 / Phase 2 | 2026-08-05 | NCT02350205 | |
| Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 4 | 2026-07-22 | NCT07094048 | |
| Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-07-17 | NCT05592938 | |
| PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) | anxiety disorder, depressive disorder, psychiatric disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-10 | NCT04754061 | |
| Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. | Digestive System Diseases, fatty liver disease, liver disorder | Recruiting | Not applicable | 2026-07-02 | NCT06843148 | |
| Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. | Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasm Recurrence, Local, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, digestive system disorder, injury, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, radiation injury, urinary system disorder | Recruiting | Not applicable | 2026-07-01 | NCT07483658 | |
| Optimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Active, not recruiting | Not applicable | 2026-07-01 | NCT06884540 | |
| OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Not yet recruiting | Not applicable | 2026-06-25 | NCT07668661 | |
| Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, female reproductive system disorder, vulvar disease, vulvodynia | Recruiting | Not applicable | 2026-05-12 | NCT07534345 | |
| Self-questionnaire in Osteoporosis | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Not stated | 2026-05-08 | NCT07067827 | |
| Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, low grade glioma, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neuroepithelial neoplasm, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, plexiform neurofibroma, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-04-24 | NCT03363217 | |
| Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Not yet recruiting | Not applicable | 2026-04-13 | NCT07525856 | |
| Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene | neoplasm | Recruiting | Not applicable | 2026-03-31 | NCT06817694 | |
| Paravertebral Block for Mastectomy With Immediate Reconstruction | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Not applicable | 2026-03-19 | NCT06276257 | |
| Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, endocrine system disorder, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, malignant endocrine neoplasm, malignant pancreatic neoplasm, metabolic disease, metastatic malignant neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Early phase 1 | 2026-03-19 | NCT04862260 | |
| Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin disease | Active, not recruiting | Early phase 1 | 2026-03-19 | NCT04171661 | |
| GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hallopeau-Siemens Disease, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, hereditary disease, hereditary skin disorder, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease | Recruiting | Phase 1 / Phase 2 | 2026-03-18 | NCT07193134 | |
| Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease | Skin and Connective Tissue Diseases, Undifferentiated Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder | Recruiting | Not applicable | 2026-03-17 | NCT06399822 | |
| A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer. | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-02-17 | NCT06052683 | |
| Activated CHARcoal in Poisoned Patient - Pilot Trial | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections, poisoning | Recruiting | Phase 4 | 2026-01-29 | NCT05471479 | |
| Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart | Infections, RNA Virus Infections, avian influenza, bird disease, influenza, non-human animal disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-01-16 | NCT07275060 | |
| Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE) | Genital Diseases, Inflammation, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not stated | 2025-12-30 | NCT03383016 |